<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR114">
 <label>114.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Sherman</surname>
    <given-names>M</given-names>
   </name>
   <name>
    <surname>Yurdaydin</surname>
    <given-names>C</given-names>
   </name>
   <name>
    <surname>Simsek</surname>
    <given-names>H</given-names>
   </name>
   <name>
    <surname>Silva</surname>
    <given-names>M</given-names>
   </name>
   <name>
    <surname>Liaw</surname>
    <given-names>Y-F</given-names>
   </name>
   <name>
    <surname>Rustgi</surname>
    <given-names>VK</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Entecavir therapy for lamivudine-refractory chronic hepatitis B: improved virologic, biochemical, and serology outcomes through 96 weeks</article-title>
  <source>Hepatology</source>
  <year>2008</year>
  <volume>48</volume>
  <fpage>99</fpage>
  <lpage>108</lpage>
  <?supplied-pmid 18537189?>
  <pub-id pub-id-type="pmid">18537189</pub-id>
 </element-citation>
</ref>
